Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

169.89 +1.17 (+0.69%)
Streaming Delayed Price Updated: 10:15 AM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Jazz Pharmaceuticals plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
Pot Stocks: Values Or Traps? ↗
Pot stocks were the hottest thing around five years ago but after catching a bid during the pandemic, the stocks have now plunged to multi-year lows. 
Via Talk Markets
Topics Cannabis
News headline image
3 Biotech Stocks That Could Be Millionaire Makers ↗
Many biotech stocks offer exciting long-term growth prospects. 
Via The Motley Fool
News headline image
Police Boss Turned Cannabis Reform Advocate, MMJ Legalization In Japan And More Global Updates ↗
Medical Cannabis-Based Epidiolex Advances Through Japan's Legislature Earlier this week, Japanese policymakers gave the green light to a measure to legalize medical products derived from cannabis,... 
Via Benzinga
Topics Cannabis
News headline image
3 No-Brainer Stocks to Buy With $200 Right Now ↗
A modest amount of money can go a long way when it's invested in inexpensive, game-changing businesses. 
Via The Motley Fool
News headline image
7 Healthcare Stocks That Are Poised to Become the Next Unicorns ↗
Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments. 
Via InvestorPlace
News headline image
Jazz Pharmaceuticals: Q3 Earnings Insights ↗
 
Via Benzinga
News headline image
Where Jazz Pharmaceuticals Stands With Analysts ↗
 
Via Benzinga
News headline image
Expert Ratings for Jazz Pharmaceuticals ↗
 
Via Benzinga
News headline image
Cannabis Cash Burn Concerns? Sell These 7 Overbought Stocks Now. ↗
These overbought cannabis stocks are teetring on the edge as the sector is navigating through uncharted waters. 
Via InvestorPlace
Topics Cannabis
News headline image
FDA Report On Its 50 Years In Cannabis Research, Signals A Boost In Medical Marijuana Prospects ↗
Researchers with the Food and Drug Administration (FDA) reported Wednesday on the agency’s 50 years of experience with marijuana research. In an article titled “FDA’s 50 
Via Benzinga
Topics Cannabis
News headline image
Ireland Reimburses Medical Marijuana-Based Drug For Chemotherapy-Induced Nausea And Vomiting ↗
Althea Group Holdings Limited (ASX: AGH), an Australian manufacturer of cannabis-based medicines and recreational cannabis products confirmed that Ireland’s Primary Care Reimbursement... 
Via Benzinga
Topics Cannabis
News headline image
Europe's High: UK Parents Need NHS Help For Daughter's Seizures, THC MMJ Flowers In Switzerland & More ↗
Luxembourg: Medical Marijuana Shortage Due To Supplier Change 
Via Benzinga
Topics Cannabis Supply Chain
News headline image
Cannabis Stocks Dip: How Rising Interest Rates Impact Your Portfolio ↗
On Friday, cannabis stocks traded lower with the overall market. Marketfy analyst Michael Berger will be monitoring how the sector performs this week. 
Via Benzinga
Topics Cannabis
News headline image
Europe's High: Irish GPs Against Pot, Switzerland-Spain Share Data On Cannabis Clubs & More ↗
Denmark: Medical Marijuana Pilot Program Experience 90% Growth In 12 Months 
Via Benzinga
Topics Cannabis
News headline image
Jazz Pharmaceuticals Explores Asset Sale Option, Possibly Cannabinoid Business: Report ↗
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) is reportedly exploring strategic options comprising a potential sale. 
Via Benzinga
News headline image
2 Top Biotech Stocks to Buy in October ↗
Growth catalysts lie ahead for both of these players. 
Via The Motley Fool
News headline image
5 Genius Safe Stocks to Buy for the 4th Quarter of 2023 ↗
These highly profitable, time-tested companies can deliver for their shareholders in any economic climate. 
Via The Motley Fool
News headline image
4 Perfect Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip ↗
An 18% decline in the Nasdaq Composite from its all-time high means bargains still abound. 
Via The Motley Fool
Topics Stocks
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023 ↗
 
Via Benzinga
News headline image
3 Cannabis Stocks That Should Be on Every Investor’s Radar This Fall ↗
The cannabis industry is a quiet place where huge upside potential is building up. As more regions legalize, cannabis stocks can soar. 
Via InvestorPlace
Topics Cannabis
News headline image
3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall ↗
Even with higher for longer interest rates, drug discovery moves on. That’s why it’s still a good time to look for biotech stocks to buy. 
Via InvestorPlace
News headline image
7 Cannabis Stocks to Buy BEFORE the Marijuana Rescheduling Boom ↗
Cannabis stocks re seeing renewed interest and these seven look like reasonable buys as rescheduling approaches for weed. 
Via InvestorPlace
Topics Cannabis
News headline image
Cannabis Industry Changes As Marijuana Rescheduling Looms ↗
As the Benzinga Cannabis Capital Conference returns to Chicago this Sept 27-28 for its 17th edition, gathering top CEOs, investors and leaders in the cannabis industry, let's scroll through the top... 
Via Benzinga
Topics Cannabis
News headline image
NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years ↗
NY-based strategic consulting firm Research Nester launched global market research for psychedelic substances with projections until 2035. 
Via Benzinga
News headline image
Prediction: These Could Be the Best-Performing Cannabis Stocks Through 2030 ↗
These two businesses may be sound, but generating returns in this industry has been tough, with no light at the end of the tunnel. 
Via The Motley Fool
Topics Cannabis
News headline image
Epidiolex Counterpart Debuts In Brazil's Cannabis Market As Its Maker Eyes TSX IPO ↗
Verdemed, a pharmaceutical company known for producing cannabis-derived products, has received five fresh approvals from the Brazilian Health Regulatory Agency (Agência Nacional de Vigilância... 
Via Benzinga
Topics Cannabis
News headline image
Jazz Pharmaceuticals' Neuroscience Pipeline Readouts In Focus: Analyst Lowers Price Target ↗
Cantor Fitzgerald analyst Charles C. 
Via Benzinga
News headline image
Jazz Pharmaceuticals Reports Q2 2023 Net Income Of $104.4M, What About Total Revenues? ↗
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced its financial results for the second quarter of 2023, along with its outlook for the remainder of the year. 
Via Benzinga
News headline image
3 Biotech Stocks You’ll Regret Not Buying Soon ↗
These top biotech stocks are must-buys with huge potential, leading the industry with high-rewards for investors. 
Via InvestorPlace
News headline image
Cannabis Stock Gainers And Losers From August 11, 2023 ↗
 
Via Benzinga
Topics Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.